Screening for specific biomarkers in the serum of postmenopausal osteoporosis patients using proteomic fingerprint techniques

Li,Weixing; Liu,Chibo; Wang,Haibao

doi:10.3892/br.2012.12

Screening for specific biomarkers in the serum of postmenopausal osteoporosis patients using proteomic fingerprint techniques

Authors:
- Weixing Li
- Chibo Liu
- Haibao Wang
View Affiliations

Affiliations: Center of Laboratory Medicine, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Clinical Laboratory, Taizhou Municipal Hospital, Taizhou, Zhejiang 318000, P.R. China, Department of Orthopedics, Taizhou Municipal Hospital, Taizhou, Zhejiang 318000, P.R. China
Published online on: September 25, 2012 https://doi.org/10.3892/br.2012.12
Pages: 129-133

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to detect serum protein biomarkers and establish a diagnostic model for postmenopausal osteoporosis (PMOP) adopting matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) combined with weak cationic exchange (WCX) magnetic beads, and to study the clinical significance of the model in the early diagnosis of PMOP. Serum samples from 45 patients with PMOP, 30 patients with osteopenia and 40 healthy controls were prepared using WCX magnetic beads, and were then analyzed using a PBSⅡ-C mass spectrometer reader. The protein spectra of the serum samples were normalized using the Ciphergen Proteinchip software. The peak labeling was performed using the Biomarker Wizard software. The specific protein biomarkers were screened using the Biomarker Pattern software to construct a diagnostic model for PMOP. A total of 138 discriminative mass-to-charge (m/z) ratios were found to be associated with PMOP. Of these, the m/z peaks at 3167.4, 4071.1, 7771.7 and 8140.5 were used to construct a diagnostic model in a training set. In a test set, the sensitivity and specificity of the model were 91.11 and 92.86%, respectively. Potential protein biomarkers for PMOP were detected in patient serum using MALDI-TOF MS combined with WCX magnetic beads. This model of multiple biomarkers provided a powerful and reliable diagnostic method for PMOP diagnosis with high sensitivity and specificity.

View Figures

View References

1.	Mazzuoli G, Acca M, Pisani D, et al: Annual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women. Bone. 26:381–386. 2000. View Article : Google Scholar : PubMed/NCBI
2.	Wark JD: Osteoporotic fractures: background and prevention strategies. Maturitas. 23:193–207. 1996. View Article : Google Scholar : PubMed/NCBI
3.	Li YZ, Hu CJ, Leng XM, et al: Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS. Anat Rec (Hoboken). 292:455–460. 2009. View Article : Google Scholar : PubMed/NCBI
4.	Liu C, Shen J, Pan C, et al: MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma. Am J Clin Pathol. 134:235–241. 2000. View Article : Google Scholar
5.	European Foundation for Osteoporosis and Bone Disease, National Osteoporosis Foundation: Who are candidates for prevention and treatment for osteoporosis? Osteoporos Int. 7:1–6. 1997. View Article : Google Scholar
6.	Melton LJ III, Chrischilles EA, Cooper C, et al: Perspective. How many women have osteoporosis? J Bone Miner Res. 7:1005–1010. 1992. View Article : Google Scholar : PubMed/NCBI
7.	Nelson HD, Helfand M, Woolf SH and Allan JD: Screening for postmenopausal osteoporosis: A review of the evidence for the U.S. Preventive Services task force. Ann Intern Med. 137:529–541. 2002. View Article : Google Scholar : PubMed/NCBI
8.	Lappe J, Kunz I, Bendik I, et al: Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study. Eur J Nutr. Feb 3–2012.(Epub ahead of print). View Article : Google Scholar
9.	Papierska L, Rabijewski M, Kasperlik-Załuska A and Zgliczyński W: Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women. Adv Med Sci. 57:51–57. 2012. View Article : Google Scholar : PubMed/NCBI
10.	Voelker R: Osteoporosis screening may be needed less often than previously believed. JAMA. 307:6542012. View Article : Google Scholar : PubMed/NCBI
11.	Wang QT, Li YZ, Liang YF, et al: Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software. Anat Rec (Hoboken). 292:604–610. 2009. View Article : Google Scholar : PubMed/NCBI
12.	Liu CB, Liang Y, Pan CQ, et al: Proteome study of differential protein expression in HBV-related primary hepatic carcinoma. Chem J Chin Univ. 30:1763–1766. 2009.